| | Dear Colleague, Elsevier Business Intelligence (EBI), publisher of "The Gray Sheet", is pleased to invite you and your team to join us for IN³ Medical Device 360° London, being held April 25 and 26, 2012 at the beautiful and centrally located Millennium Gloucester Hotel & Conference Centre, London, Kensington. IN³ Medical Device 360° London is a must-attend investment and partnering event at which you will gain a full 360° view of your global market, opportunities and challenges. Building on the success of past IN³ events in Paris, Rome and Brussels, this exceptional conference will bring together start-ups from around the world seeking funding or strategic partnership, with international industry and investment experts discussing the most pressing issues facing our global industry in 2012 and beyond. The two-day program will include a variety of financing, business development, clinical/regulatory panel discussions, and networking sessions. Register today to take advantage of our discounted hotel rates through April 6th only! We look forward to having you with us in London in just a few weeks! Sincerely, Kristy J. Kennedy
Sales Director, Medical Device
Elsevier Business Intelligence
Tel (480) 985-9512
(888) 290-2225 toll-free in the U.S.
k.kennedy@elsevier.com | | | | Presenters To Date | - AiMedics Ltd. (First-Time Presenter) -- AiMedics is an Australian Innovative Medical Device Company whose mission is to successfully market the world's first non-invasive system which accurately detects and alerts users of sleep-time hypoglycaemia.
- Anethon -- Anthenon is a medical device company developing second-generation biomimetic cardiovascular prostheses, such as blood vessels, patches and heart valves.
- CellCoTec -- CellCoTec is a development-stage orthopedics company using Cellular Regeneration Technology (CRT) to provide a single-surgery solution for damaged articular cartilage in the knee.
- Endomagnetics Ltd. -- Endomagnetics is addressing cancer staging and healthcare challenges through the application of advanced magnetic sensing technology and nanotechnology.
- Enox BioPharma -- Enox is a biotechnology company with proprietary technology that embeds nitric oxide (NO) into polymer based medical devices.
- Implandata Ophthalmic Products GmbH -- Implandata is a Germany-based, early-stage, privately held medical device company that has developed a novel technology for 24-hour monitoring of intraocular pressure for the management of glaucoma patients.
- N8 Medical, Inc. -- N8's core technology is a patented class of synthetic compounds, known as ceragenins, that mimic key components of the human innate immune system.
- NUUBO -- NUUBO's vision is to become the leading provider of cardiopathy diagnosis data for the early detection and accurate diagnosis of cardiac issues.
- QSTREAM VASCULAR (First-Time Presenter) -- QSTREAM is developing a full range of cutting-edge endosuturing devices designed to accelerate and simplify total laparoscopic peripheral vascular reconstructions by addressing unmet needs in vascular surgery.
| - Replication Medical, Inc. -- Replication Medical develops innovative treatments for degenerative conditions of the spine using our proprietary hydrogel technology.
- Sapiens Steering Brain Stimulation (First-Time Presenter) -- Sapiens™ high-resolution probe enables the reduction of stimulation-induced side effects in Deep Brain Stimulation for patients with Parkinson's disease by precisely steering tiny stimulation currents to the intended target area.
- Sensible Medical Innovation Ltd. (First-Time Presenter) - Sensible Medical is introducing a sensing and monitoring technology providing actionable and accurate data for guiding the management and treatment of several chronic medical conditions representing today's biggest burden on US and worldwide healthcare budgets.
- Soft Tissue Regeneration Inc. -- STR has developed and preliminarily tested a potential breakthrough technology for soft tissue regeneration of the anterior cruciate ligament (ACL) of the knee.
- Specialty Scanners plc (First-Time Presenter) -- Specialty Scanners is a company with a portfolio of several MRI-compatible products designed to enable the provision of minimally invasive diagnostic and thermal energy (e.g., cryosurgery) treatment procedures under real-time MRI guidance using the company's proprietary Intra-Operative MR Scanner.
- Vantix Ltd. (First-Time Presenter) -- Vantix offers their point-of-care blood analyzer, in which a pin prick blood sample is placed on a disposable cartridge and inserted into a reader, with lab-quality results in 5 minutes.
- Vascular Flow Technologies Ltd. (First-Time Presenter) -- Vascular Flow Technologies Ltd (VF) is focused on the research, development and commercialisation of vascular devices based on a new understanding of blood flow dynamics - Spiral Laminar Flow™ (SLF™ technology).
- Many more companies being added regularly. Apply today!
| | Event Highlights | | Corporate Buy-Side Perspective Panel: What are Buyers Looking for in 2012?
In this interactive session, large device company executives share their insights and perspectives, offering insights on what they like to see from smaller venture-backed companies. Confirmed Participants to Date (guest bios): - David Cassak, VP of Content, Elsevier Business Intelligence (moderator)
- Steve Levin, Editor-in-Chief, Elsevier Business Intelligence (moderator)
- Arnaud Bernaert, SVP, Corporate Mergers and Acquisitions, Philips
- Stan Rabinovich, VP, Advanced Technology, Edwards Lifesciences
- Townsend Goddard, Director, Business Development & Strategic Planning, Stryker
- Edward Andrle, VP, Business Development & Strategy, Sorin Group
- Bulend Corbacioglu, VP, Business Development and Licensing, Covidien
Featured Panel: Business Challenges Facing Wireless Health Ventures
This interactive panel consisting of speakers from different sectors of the mobile health ecosystem will explore the challenges facing various wireless health ventures, such as how to secure innovation funding, which mobile health apps and devices face regulation; and how to monetize wireless health by targeting clinicians, payers or consumers. Confirmed Participants to Date (guest bios): - Victor Higgs, Managing Director, Applied Nanodetectors Ltd.
- Bleddyn Rees, Head of Healthcare, Wragge & Co LLP and Director, ECHAlliance
- William F. McKeon, Chief Executive Officer, Cellnovo Ltd.
VC Panel Discussion: Raising Venture Capital in Europe: The Best of Times or the Worst of Times?
In this interactive session, investors share their insights and perspectives based on actual company presentations, offering insights on what they like to see from smaller venture-backed companies. Confirmed Participants to Date (guest bios): - David Cassak, VP of Content, Elsevier Business Intelligence (moderator)
- Steve Levin, Editor-in-Chief, Elsevier Business Intelligence
- Thom Rasche, Partner, Earlybird Venture Capital
- Alan O'Connell, Partner, Seroba Kernel Life Sciences
- Aris Constantinides, Investment Director, NBGI Ventures
- Antoine Papiernik, Managing Partner, Sofinnova Partners
And Much More: - Profile Presentations by the following healthcare investment firms, among others: Forbion, Gilde Healthcare Partners, Fountain Healthcare Partners, Wellington Partners, Delta Partners, Peppermint VP, Family Office Fund
- Each registered attendee is able to access our proprietary, state-of-the-art partnering software - pre-schedule private one-on-one meetings so that when you arrive in London, you have a schedule of meetings with potential partners.
- More networking opportunities added
| | | | | |  You have received this email because you registered at BioSpace. BioSpace regularly sends emails to active subscribers on behalf of our advertising partners or to promote our own products and services.
If you would like to stop receiving all email communications from BioSpace, you can unsubscribe at any time by clicking here.
BioSpace
6465 South Greenwood Plaza, Suite 400, Centennial, CO 80111, U.S.
(888) BIOSPACE |
|
No comments:
Post a Comment